Stock Acquisition Rights Intended to Strengthen Commitment to Business Growth
First written in FY2017-Q1. 2 of 7 entries say "Restated". Latest entry: FY2027-H1.
- FY2027-H1Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「Increase in total number of issued shares: 18,000 … This resulted from the exercise of stock acquisition rights (stock options).」
During the current interim accounting period, 18,000 shares were added through the exercise of stock acquisition rights. The disclosure concerns the exercise of previously issued rights, not the issuance of new stock acquisition rights. - FY2026RestatedAnnual report
「At a meeting of the Board of Directors held on 18 August 2025, the company resolved to issue share acquisition rights as described below and issued them on 9 September of the same year.」
The company continues to disclose the issuance on 9 September 2025 of the Series 4 and Series 5 share acquisition rights for employees, with 142,000 shares and 59,000 shares, respectively, remaining unsettled. - FY2026-H1AdvancedAnnual report
「At a meeting of the Board of Directors held on 18 August 2025, the company resolved to issue share acquisition rights as described below and issued them on 9 September of the same year.」
On 9 September 2025, the company issued 1,480 Series 4 share acquisition rights covering 148,000 shares and 590 Series 5 share acquisition rights covering 59,000 shares to employees of the company and its subsidiaries. The exercise period for both series is from 18 August 2027 to 18 August 2035. - FY2024-Q3ReframedAnnual report
「At a meeting of the Board of Directors held on 20 November 2023, the company resolved to issue share acquisition rights as described below and issued them on 11 December of the same year.」
For share acquisition rights aimed at strengthening the commitment to business expansion, the company newly issued 3 types of rights, targeting the representative director, officers and employees of the company and its subsidiaries, and external collaborators: share-price-based, operating-profit-based, and share-compensation-based rights. - FY2019-Q3DroppedAnnual report
「Not applicable.」
The status of share acquisition rights and other instruments is reported as not applicable, and the share acquisition rights previously disclosed as aimed at strengthening the commitment to business expansion are no longer included. - FY2017-Q2RestatedAnnual report
「Number of share acquisition rights (units): 884; number of shares underlying the share acquisition rights (shares): 884,000; exercise period: 1 June 2017 to 31 May 2020」
The company discloses the issuance of 884 share acquisition rights covering 884,000 shares and their exercise period, aimed at strengthening its commitment to business expansion. - FY2017-Q1First statedAnnual report
「To further strengthen its commitment to business expansion as it seeks to increase the Group’s corporate value over the medium to long term, the company allotted paid share acquisition rights on 5 July 2016 to its directors, executive officers, employees, external collaborators (advisors), and the directors, executive officers, and employees of its subsidiaries, and received payment on the same day.」
The company introduced paid share acquisition rights for directors, executive officers, employees, external collaborators, and others as a means of strengthening its commitment to increasing corporate value and expanding business performance.